Dynamic Estimation of Cardiac Output in the Operating Room
TRIPLEFLOW
Estimation of Cardiac Output in the Operating Room by Pulse Wave Analysis and Esophageal Doppler Blood Velocity: Comparison of the Two Methods
2 other identifiers
observational
92
1 country
1
Brief Summary
During major surgery, it is recommended to monitor invasive arterial blood pressure and cardiac output (CO) during hemodynamic interventions (fluid challenge or vasopressors). Esophageal Doppler is currently considered as the reference method for monitoring cardiac output in the operating room. The PRAM method (pressure recording analytical method) with the MostCareUp monitor (Vytech, Padova, Italy) and the LTIA method (long time interval analysis) allow cardiac output estimation derived from non-calibrated arterial pressure waveform analysis. Few studies have looked at relative changes in cardiac output during hemodynamic intervention with these two methods. The aim of this study is to compare the relative changes in cardiac output during hemodynamic interventions as measured using PRAM and LTIA methods, compared to esophageal Doppler.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 7, 2021
CompletedFirst Posted
Study publicly available on registry
June 15, 2021
CompletedStudy Start
First participant enrolled
September 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2024
CompletedOctober 18, 2021
June 1, 2021
2 years
June 7, 2021
October 11, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Cardiac output using the trans-esophageal Doppler technique
Measure of cardiac output with trans-esophageal doppler (CARDIOQ-ODM; Deltex Medical, Chichester, UK) in L/min (COTOD)
Duration of the surgery (maximum 1 day)
Cardiac output using the MostCareUp monitor
Measure of cardiac output with MostCareUp (Vytech, Padova, Italy) in L/min (COPRAM)
Duration of the surgery (maximum 1 day)
Cardiac output using the Argos monitor
Measure of cardiac output with Argos monitor (Retia Medical, Valhalla, NY, USA) in L/min (COLTIA)
Duration of the surgery (maximum 1 day)
Secondary Outcomes (7)
Measure of the value of the dicrote wave with MostCareUp monitor
Duration of the surgery (maximum 1 day)
Measure of dP/dtmax (myocardial contractility index) with MostCareUp monitor
Duration of the surgery (maximum 1 day)
Measure of the cardiac efficiency (CCE) with MostCareUp monitor
Duration of the surgery (maximum 1 day)
Measure of arterial elastance with MostCareUp monitor
Duration of the surgery (maximum 1 day)
Measure of the total impedance of the system (Ztot) with MostCareUp monitor
Duration of the surgery (maximum 1 day)
- +2 more secondary outcomes
Study Arms (1)
Patients undergoing general anesthesia and benefiting from intraoperative hemodynamic optimization
Patients undergoing general anesthesia and benefiting from intraoperative hemodynamic optimization, including routine monitoring of blood pressure and measurement of cardiac output by trans-esophageal Doppler.
Interventions
Trans-esophageal Doppler monitoring (CARDIOQ-ODM; Deltex Medical, Chichester, UK) for monitoring of cardiac output
MostCareUp (Vytech, Padova, Italy) waveform analysis cardiac output monitor
Argos monitor (Retia Medical, Valhalla, NY, USA) for cardiac output monitoring
Eligibility Criteria
Adult patients eligible for an interventional radiology procedure, surgery under general anesthesia, or admitted to intensive care unit for postoperative organ failure, benefiting from intraoperative and postoperative hemodynamic optimization in intensive care including routine blood pressure monitoring and measurement of cardiac output by esophageal Doppler.
You may qualify if:
- Major patients (≥ 18 years )
- Eligible for an interventional radiology procedure or surgery under general anesthesia
- Monitoring of invasive blood pressure and cardiac output by trans-esophageal Doppler.
- Patients informed and having expressed their non-opposition to participation in this research
You may not qualify if:
- Patients under 18 years old
- Atrial fibrillation
- Contraindication to trans-esophageal doppler
- Patient opposed to protocol participation
- Pregnant woman
- Patient under judicial protection
- Patient without affiliation to a social security scheme
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AP-HP, Lariboisière Hospital, Department of Anesthesiology and Intensive Care
Paris, 75010, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alex HONG, MD
Assistance Publique - Hôpitaux de Paris
- STUDY DIRECTOR
Joaquim MATEO, MD
Assistance Publique - Hôpitaux de Paris
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 7, 2021
First Posted
June 15, 2021
Study Start
September 15, 2021
Primary Completion
September 1, 2023
Study Completion
March 1, 2024
Last Updated
October 18, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share